Assembly Biosciences (ASMB) Total Current Liabilities (2010 - 2026)
Assembly Biosciences (ASMB) posted quarterly Total Current Liabilities of $35.0 million for Q1 2026, down 24.95% year-over-year from $46.6 million in Q1 2025, and down 28.26% quarter-over-quarter from $48.8 million in Q4 2025.
Assembly Biosciences (ASMB) Total Current Liabilities (2010 - 2026) Analysis & Trends
Assembly Biosciences' Total Current Liabilities history runs 17 years deep, the most recent figure standing at $35.0 million for Q1 2026.
- In Q1 2026, Total Current Liabilities fell 24.95% year-over-year to $35.0 million; the TTM figure through Mar 2026 stood at $35.0 million (down 24.95% YoY), while the FY2025 annual figure was $48.8 million, up 2.04% from the prior year.
- Total Current Liabilities for Q1 2026 stood at $35.0 million, down from $48.8 million in the prior quarter.
- The five-year high for Total Current Liabilities was $53.4 million in Q3 2025, with the low at $7.1 million in Q3 2023.
- The 5-year median for Total Current Liabilities is $38.8 million (2024), against an average of $30.8 million.
- The sharpest annual moves came in 2023 and 2024: Total Current Liabilities plunged 53.87% in 2023, then jumped 483.78% in 2024.
- Assembly Biosciences' Total Current Liabilities stood at $16.3 million in 2022, then soared by 140.7% to $39.2 million in 2023, then climbed by 21.87% to $47.8 million in 2024, then rose by 2.04% to $48.8 million in 2025, then fell by 28.26% to $35.0 million in 2026.
- Business Quant data shows ASMB's Total Current Liabilities at $35.0 million in Q1 2026, $48.8 million in Q4 2025, and $53.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 3.94 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 5.53 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.58 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 354.06 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 2.12 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4.22 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 630.93 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.51 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 438.74 Mn |
| 10 | Assembly Biosciences | 670.88 Mn | 350.52 Mn | - | 23.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 23.45 Mn |
| Mar 31, 2026 | 35.00 Mn |
| Dec 31, 2025 | 48.78 Mn |
| Sep 30, 2025 | 53.38 Mn |
| Jun 30, 2025 | 47.29 Mn |
| Mar 31, 2025 | 46.63 Mn |
| Dec 31, 2024 | 47.80 Mn |
| Sep 30, 2024 | 41.64 Mn |
| Jun 30, 2024 | 41.27 Mn |
| Mar 31, 2024 | 38.75 Mn |
| Dec 31, 2023 | 39.23 Mn |
| Sep 30, 2023 | 7.13 Mn |
| Jun 30, 2023 | 8.83 Mn |
| Mar 31, 2023 | 9.97 Mn |
| Dec 31, 2022 | 16.30 Mn |
| Sep 30, 2022 | 15.46 Mn |
| Jun 30, 2022 | 14.96 Mn |
| Mar 31, 2022 | 10.71 Mn |
| Dec 31, 2021 | 16.07 Mn |
| Sep 30, 2021 | 14.93 Mn |